TGF-β, NF-κB, VEGF, AKT, and PI3K were selected as alternative biomarkers based on previous investigations, and blood platelets were tested in 20 confirmed HCC patients and 10 control samples [216]. Here, AKT1 is linked to hepatocellular carcinoma.